# Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients

> **NCT03453307** · — · UNKNOWN · sponsor: **K2 Oncology, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- NSCLC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03453307
- **Lead sponsor:** K2 Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-30
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453307, "Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03453307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*